Morgan D A, Bradley P J, MacLennan K A
Head and Neck Oncology Unit, General Hospital, Nottingham, England.
Acta Oncol. 1987;26(6):437-40. doi: 10.3109/02841868709113714.
Fifteen patients with stage III or IV squamous cell carcinoma of the larynx were treated by primary radiotherapy using a schedule of 3 small (1.1-1.5 Gy) fractions per day, an interval between fractions of 3-4 h, and a total dose of approximately 60 Gy. Primary tumour control was achieved in 13 cases, but in one of these neck node metastases were not controlled. Acute mucosal reactions were brisk, but tolerable; late complications were severe in 3 patients. Early, encouraging results in terms of tumour response must be tempered by caution over the late damage: a number of factors probably contribute to this, especially interval between fractions and total dose. From a practical viewpoint, the latter may be easier to influence, if 3 small fractions per day are to continue to be used.
15例Ⅲ期或Ⅳ期喉鳞状细胞癌患者接受了根治性放疗,采用每天3次小剂量(1.1 - 1.5 Gy)分割照射,分割间隔为3 - 4小时,总剂量约60 Gy。13例患者的原发肿瘤得到控制,但其中1例颈部淋巴结转移未得到控制。急性黏膜反应明显但可耐受;3例患者出现严重的晚期并发症。尽管在肿瘤反应方面取得了早期令人鼓舞的结果,但对于晚期损伤必须谨慎对待:许多因素可能导致这种情况,尤其是分割间隔和总剂量。从实际角度来看,如果继续采用每天3次小剂量分割照射,后者可能更容易控制。